Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTH
3201
DELISTED
Genetron Holdings Limited ADS
GTH
| $124K | ﹤0.01% |
50,700
-133
| -0.3% | -$361 |
|
3202
Alset
AEI
$42M
| $123K | ﹤0.01% |
92,966
-100
| -0.1% | -$152 |
|
|
TMQ
3203
Trilogy Metals
TMQ
$608M
| $123K | ﹤0.01% |
251,500
-65,800
| -21% | -$33.5K |
|
3204
Tonix Pharmaceuticals
TNXP
$180M
| $122K | ﹤0.01% |
70
+4
| +6% | +$14.6K |
|
|
CYAN
3205
DELISTED
Cyanotech Corp
CYAN
| $122K | ﹤0.01% |
152,209
-2,300
| -1% | -$1.89K |
|
3206
Aura Biosciences
AURA
$725M
| $121K | ﹤0.01% |
13,500
-6,000
| -31% | -$64.5K |
|
3207
Celularity
CELU
$20.3M
| $121K | ﹤0.01% |
54,340
+26,899
| +98% | +$96.6K |
|
3208
LiveWire
LVWR
$270M
| $121K | ﹤0.01% |
+17,502
| New | +$186K |
|
3209
Skillsoft
SKIL
$72.3M
| $121K | ﹤0.01% |
6,810
+2,620
| +63% | +$66.4K |
|
|
BRAG
3210
Bragg Gaming Group
BRAG
$52.4M
| $120K | ﹤0.01% |
24,600
+8,200
| +50% | +$39.5K |
|
3211
5E Advanced Materials
FEAM
$52.3M
| $120K | ﹤0.01% |
2,300
-2,513
| -52% | -$171K |
|
|
HIVE
3212
HIVE Digital Technologies
HIVE
$788M
| $120K | ﹤0.01% |
39,020
-314,480
| -89% | -$1.34M |
|
|
ADN
3213
DELISTED
Advent Technologies
ADN
| $118K | ﹤0.01% |
10,070
-8,400
| -45% | -$165K |
|
3214
Definitive Healthcare
DH
$69.4M
| $118K | ﹤0.01% |
+14,800
| New | +$149K |
|
3215
HeartCore Enterprises
HTCR
$3.72M
| $118K | ﹤0.01% |
5,960
-418
| -7% | -$10.3K |
|
3216
Oramed Pharmaceuticals
ORMP
$183M
| $116K | ﹤0.01% |
44,300
+10,600
| +31% | +$33.4K |
|
|
HITI
3217
High Tide
HITI
$196M
| $115K | ﹤0.01% |
62,200
+38,587
| +163% | +$55.2K |
|
3218
Gray Media Inc
GTN.A
$679M
| $114K | ﹤0.01% |
15,200
+300
| +2% | +$2.68K |
|
3219
IZEA Worldwide
IZEA
$60.4M
| $114K | ﹤0.01% |
52,503
+6,478
| +14% | +$14.9K |
|
|
PVLA
3220
Palvella Therapeutics
PVLA
$2.18B
| $114K | ﹤0.01% |
4,766
+147
| +3% | +$3.16K |
|
|
FRLN
3221
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $113K | ﹤0.01% |
26,360
+4,500
| +21% | +$17.8K |
|
|
VOXR
3222
Vox Royalty Corp
VOXR
$334M
| $112K | ﹤0.01% |
55,400
+42,200
| +320% | +$94.5K |
|
|
ZEPP
3223
Zepp Health
ZEPP
$68M
| $112K | ﹤0.01% |
24,300
-250
| -1% | -$1.18K |
|
3224
Rani Therapeutics
RANI
$88.7M
| $111K | ﹤0.01% |
51,000
-37,201
| -42% | -$142K |
|
|
UCL
3225
uCloudlink Group
UCL
$29.4M
| $111K | ﹤0.01% |
52,405
-4,800
| -8% | -$12.4K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.